Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders
- 1 December 2018
- journal article
- review article
- Published by Elsevier in Cancer Genetics
- Vol. 228-229, 184-196
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Array-Based Karyotyping in Plasma Cell Neoplasia After Plasma Cell Enrichment Increases Detection of Genomic AberrationsAmerican Journal of Clinical Pathology, 2012
- High detection rate of clinically relevant genomic abnormalities in plasma cells enriched from patients with multiple myelomaGenes, Chromosomes and Cancer, 2012
- Genomic analysis of high-risk smoldering multiple myelomaHaematologica, 2012
- Initial genome sequencing and analysis of multiple myelomaNature, 2011
- Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myelomaBlood, 2007
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaCancer Cell, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern DenmarkCancer Genetics and Cytogenetics, 2007
- Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myelomaBlood, 2006
- IL‐4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphasesBritish Journal of Haematology, 1998